Vericel Corp Ord

NASDAQ:VCEL USA Biotechnology
Market Cap
$1.65 Billion
Market Cap Rank
#5557 Global
#3266 in USA
Share Price
$32.50
Change (1 day)
+0.65%
52-Week Range
$29.84 - $47.96
All Time High
$67.81
About

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the … Read more

Vericel Corp Ord (VCEL) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: 0.042x

Based on the latest financial reports, Vericel Corp Ord (VCEL) has a cash flow conversion efficiency ratio of 0.042x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($15.01 Million) by net assets ($354.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vericel Corp Ord - Cash Flow Conversion Efficiency Trend (1995–2025)

This chart illustrates how Vericel Corp Ord's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Vericel Corp Ord Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vericel Corp Ord ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Vericel Corp Ord (1995–2025)

The table below shows the annual cash flow conversion efficiency of Vericel Corp Ord from 1995 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $354.64 Million $51.91 Million 0.146x -26.52%
2024-12-31 $291.97 Million $58.16 Million 0.199x +27.47%
2023-12-31 $225.95 Million $35.31 Million 0.156x +69.89%
2022-12-31 $192.27 Million $17.69 Million 0.092x -46.00%
2021-12-31 $170.46 Million $29.04 Million 0.170x +30.17%
2020-12-31 $134.26 Million $17.57 Million 0.131x +302.42%
2019-12-31 $111.09 Million $-7.18 Million -0.065x -1504.40%
2018-12-31 $102.23 Million $-412.00K -0.004x +99.31%
2017-12-31 $22.54 Million $-13.18 Million -0.585x +27.35%
2016-12-31 $24.71 Million $-19.89 Million -0.805x -33.49%
2015-12-31 $22.13 Million $-13.35 Million -0.603x +15.41%
2014-12-31 $35.64 Million $-25.41 Million -0.713x +86.08%
2013-12-31 $3.89 Million $-19.94 Million -5.121x -64.90%
2012-12-31 $9.51 Million $-29.55 Million -3.106x -264.48%
2011-12-31 $-12.97 Million $-24.49 Million 1.888x +136.58%
2010-12-31 $2.92 Million $-15.09 Million -5.163x -546.36%
2009-12-31 $17.28 Million $-13.80 Million -0.799x +4.56%
2008-12-31 $23.33 Million $-19.53 Million -0.837x -59.46%
2007-12-31 $28.25 Million $-14.83 Million -0.525x -64.38%
2006-12-31 $42.34 Million $-13.52 Million -0.319x +4.70%
2005-12-31 $33.03 Million $-11.06 Million -0.335x +38.07%
2004-12-31 $17.61 Million $-9.53 Million -0.541x +30.35%
2003-12-31 $11.57 Million $-8.99 Million -0.777x +4.10%
2002-12-31 $10.80 Million $-8.75 Million -0.810x -38.68%
2001-12-31 $10.89 Million $-6.36 Million -0.584x -5.60%
2000-12-31 $12.44 Million $-6.88 Million -0.553x +57.97%
1999-12-31 $8.51 Million $-11.20 Million -1.316x +8.75%
1998-12-31 $10.85 Million $-15.64 Million -1.442x -103.97%
1997-12-31 $18.81 Million $-13.30 Million -0.707x +11.77%
1996-12-31 $16.60 Million $-13.30 Million -0.801x +57.74%
1995-12-31 $4.80 Million $-9.10 Million -1.896x --